NasdaqGS - Nasdaq Real Time Price • USD
OPKO Health, Inc. (OPK)
At close: 4:00 PM EDT
After hours: 5:26 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.09 | -0.09 | -0.36 | -0.26 |
| Low Estimate | -0.14 | -0.14 | -0.57 | -0.53 |
| High Estimate | -0.06 | -0.07 | -0.27 | -0.02 |
| Year Ago EPS | -0.02 | -0.03 | -0.25 | -0.36 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 182.99M | 187.04M | 745.26M | 795.59M |
| Low Estimate | 180M | 167.5M | 685.21M | 667.9M |
| High Estimate | 184.8M | 196.5M | 790.05M | 916.23M |
| Year Ago Sales | 237.6M | 201.97M | 863.5M | 745.26M |
| Sales Growth (year/est) | -23.00% | -7.40% | -13.70% | 6.80% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.08 | -0.07 | -0.1 | -0.09 |
| EPS Actual | -0.02 | -0.03 | -0.11 | -0.09 |
| Difference | 0.06 | 0.04 | -0.01 | 0 |
| Surprise % | 75.00% | 57.10% | -10.00% | 0.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.09 | -0.09 | -0.36 | -0.26 |
| 7 Days Ago | -0.09 | -0.09 | -0.37 | -0.26 |
| 30 Days Ago | -0.09 | -0.09 | -0.36 | -0.25 |
| 60 Days Ago | -0.06 | -0.06 | -0.19 | -0.07 |
| 90 Days Ago | -0.06 | -0.06 | -0.19 | -0.07 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | OPK | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -350.00% | -- | -- | 2.60% |
| Next Qtr. | -200.00% | -- | -- | 13.40% |
| Current Year | -44.00% | -- | -- | 5.20% |
| Next Year | 27.80% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 12.00% | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/3/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 4/1/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 4/1/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 2/28/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/7/2023 |
Related Tickers
LH Laboratory Corporation of America Holdings
198.35
-4.61%
ISPC iSpecimen Inc.
0.2802
+1.12%
VNRX VolitionRx Limited
0.8902
+11.27%
LAB Standard BioTools Inc.
2.3600
-2.48%
TWST Twist Bioscience Corporation
31.08
+1.07%
ILMN Illumina, Inc.
121.05
-1.48%
DGX Quest Diagnostics Incorporated
135.42
-1.55%
XGN Exagen Inc.
1.4100
+2.92%
TTOO T2 Biosystems, Inc.
2.7400
-0.54%
GH Guardant Health, Inc.
17.16
-5.19%